Fig. 1
Intrapatient between-day FBG variability. a All patients with T1D. b Japanese patients with T1D. c Patients with T2D. Intrapatient between-day FBG variability calculated using standard deviation of FBG from SMBG (standard deviation of 3 values per visit) (bar graph; left axis). To display dispersion, mean FBG is also shown (line graph; right axis). Treatment comparisons at each visit were analyzed using ANCOVA: *p < 0.05 LY IGlar vs IGlar. For a and b, data from weeks 2, 18, 30, 44, and week 24 (LOCF) are not shown. No statistical significance was observed at these visits or endpoints. ANCOVA analysis of covariance, BL baseline, FBG fasting blood glucose, IGlar Lantus insulin glargine, LOCF last observation carried forward, LS least-squares, LY IGlar LY2963016 insulin glargine, N number of patients with data, SMBG self-monitored blood glucose, T1D type 1 diabetes, T2D type 2 diabetes